As of 2024-09-14, the Relative Valuation of Intercept Pharmaceuticals Inc (ICPT) is (38.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.00 USD, the upside of Intercept Pharmaceuticals Inc based on Relative Valuation is -301.3%.
The range of the Relative Valuation is (28.09) - (37.75) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 34.0x | 29.4x |
| Forward P/E multiples | 19.1x - 25.6x | 22.5x |
| Fair Price | (28.09) - (37.75) | (38.24) |
| Upside | -247.8% - -298.7% | -301.3% |
| Date | P/E |